|
Antibody
Investigational
Unknown
Unknown
Carcinoma; Adenocarcinoma; Adenocarcinoma, Clear Cell; Biliary Tract Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Endometrial Neoplasms; Gallbladder Neoplasms; Glioblastoma; Granuloma, Lethal Midline; Hemangiosarcoma; Histiocytoma, Malignant Fibrous; Immunoblastic Lymphadenopathy; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Mesothelioma; Mouth Neoplasms; Nasopharyngeal Carcinoma; Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Hodgkin Disease; Lung Neoplasms; Nasopharyngeal Neoplasms; Stomach Neoplasms
Programmed cell death protein 1 antagonist
|
